Orion Pharma
Orion Corporation (Finnish: Orion Oyj), founded in 1917 and headquartered at Espoo, Finland, is a globally operating Finnish company which develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients for global markets. All of the company's manufacturing sites and the majority of its R&D units are in Finland.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Comtan | Entacapone | 1999-10-19 | ||
| Comtess | Entacapone | 1998-09-16 | ||
| Corbilta (previously levodopa/carbidopa/entacapone sandoz) | Entacapone, Levodopa, Carbidopa hydrate | 2013-11-11 | ||
| Dexdor | Dexmedetomidine | 2011-09-15 | 2032-2039 | |
| Entacapone orion | Entacapone | 2011-08-18 | ||
| Fareston | Toremifene | 1996-02-14 | ||
| Levodopa/carbidopa/entacapone orion | Entacapone, Levodopa, Carbidopa hydrate | 2011-08-23 | ||
| Stalevo | Entacapone, Levodopa, Carbidopa hydrate | 2003-06-11 |
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use